A presentation to: Meeting name Date

Slides:



Advertisements
Similar presentations
A Comparison of Early Versus Late Initiation of Renal Replacement Therapy in Critically III Patients with Acute Kidney Injury: A Systematic Review and.
Advertisements

Selective Laser Trabeculoplasty: NSAIDs vs Steroids in Post-Operative Management Jennifer Calafati MD, Donna Williams-Lyn PhD, Iqbal Ike K. Ahmed MD, FRCSC.
Will my Glaucoma patient lose vision ?
Do we understand our data? Evaluating comprehension and usefulness of statistical methods for continuous outcomes in meta-analyses Furqaan Sadiq 1, Reem.
PJ Devereaux, Population Health Research Institute, Hamilton, Canada on behalf of POISE-2 Investigators PeriOperative ISchemic Evaluation-2 Trial POISE-2POISE-2.
2012 實證醫學系統課程 第一組 報告 吳敏誠、鍾宜倫、凌久惠 2012/08/07. Acyclovir for treating primary herpetic gingivostomatitis(Review) Cochrane Library 2008, Issue 4.
Hot topics in smoking cessation Robert West University College robertjwest 1.
iStent with phacoemulsification, n=50
Effectiveness of yoga for hypertension: Systematic review and meta-analysis Marshall Hagins, PT, PhD1, Rebecca States,
María Alejandra Carrasco, MD Mendoza. Argentina
The SPRINT Research Group
Tulsi Changulani 1,*, Jenny Bo 2, Mei-Ling Cheng 1, Andrew Tatham 1
Selective laser trabeculoplasty in Korean eyes with medically uncontrolled pseudoexfoliation glaucoma Su Chan Lee1, Jung Hyun Lee1,
UOG Journal Club: October 2016
Early Intraocular Pressure Rise After Phacoemulsification In Non-Glaucomatous And Eyes With Primary Open-Angle Glaucoma Milos Todorovic 1, Suncica Sreckovic.
Lasers in Glaucoma: Meta analysis
From: Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure
A presentation to: Meeting name Date
Thomas F. O’Donnell, MD, Joseph Lau, MD  Journal of Vascular Surgery 
A presentation to: Meeting name Date
A presentation to: Meeting name Date
Frolov Mikhail, Dushina Galina
POISE-2 PeriOperative ISchemic Evaluation-2 Trial
Protocol U Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involved DME Following Anti-VEGF.
A presentation to: Meeting name Date
A presentation to: Meeting name Date
ACTIVE A Effects of Addition of Clopidogrel to Aspirin in Patients with Atrial Fibrillation who are Unsuitable for Vitamin K Antagonists.
Association between risk-of-bias assessments and results of randomized trials in Cochrane reviews: the ROBES study Jelena Savović1, Becky Turner2, David.
Courtney J. Warner, MD, MS, Spencer W. Greaves, MPH, Robin J
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
Thomas F. O’Donnell, MD, Joseph Lau, MD  Journal of Vascular Surgery 
Understanding evidence: The big picture
A presentation to: Meeting name Date
A randomized double-blind trial of upward progressive versus degressive compressive stockings in patients with moderate to severe chronic venous insufficiency 
Database-specific risk of ventricular arrhythmia associated with current use of azithromycin compared with current use of amoxicillin (2-stage random-effects.
Prehypertension and Incidence of ESRD: A Systematic Review and Meta-analysis  Yuli Huang, MD, Xiaoyan Cai, MD, Jianyu Zhang, MD, Weiyi Mai, MD, PhD, Sheng.
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
Cheil Eye Hospital , Daegu, Korea
Volume 371, Issue 9627, Pages (May 2008)
A presentation to: Meeting name Date
Comparison of Conservative Treatment and Thymectomy on Myasthenia Gravis Outcome  Emanuela Taioli, MD, PhD, Philip Kent Paschal, Bian Liu, PhD, Andrew.
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target    American.
DRCR Retina Network Treatment for Center-Involved DME in Eyes with Good Visual Acuity (Protocol V)
Presentation transcript:

A presentation to: Meeting name Date Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty Linda Zhang, Jennifer S Weizer, David C Musch Issue 2, 2017 A presentation to: Meeting name Date

Table of Contents 01 Background 02 Types of studies 03 Key results 04 Tables (Risk of Bias/Forest Plots) 05 Conclusions 06 Acknowledgements

01: Background Intraocular Pressure (IOP) is the only known modifiable risk factor for glaucoma Laser trabeculoplasty (LTP) reduces IOP, but can cause initial spikes in IOP elevation Perioperative glaucoma medications may help prevent increased IOP following LTP How effective is perioperative medication in preventing temporarily increased IOP following LTP in patients with open-angle glaucoma?

02: Types of studies Participants 22 randomized controlled trials, 2112 participants with open- angle glaucoma undergoing laser trabeculoplasty Interventions Perioperative antiglaucoma medication versus none/placebo One perioperative medication versus another The same medication administered before versus after LTP

03: Key results “the medication group had a lower risk of IOP increase of 10 mmHg or greater within two hours compared with the no medication/placebo group (risk ratio (RR) 0.05, 95% confidence interval (CI) 0.01 to 0.20)” “In our comparison of brimonidine versus apraclonidine, neither medication resulted in a lower risk of increased IOP of 5 mmHg or greater two hours of surgery”

03: Key results (continued) “In our comparison of apraclonidine versus pilocarpine, we had insufficient data to perform meta-analyses to estimate effects on either of the primary outcomes” “In the comparison of medication given before LTP versus the same medication given after LTP, we had insufficient data for meta-analysis of IOP increase within two hours.”

04: Tables IOP increase of > mmHg 2-24 hours after LTP

04: Tables IOP increase of > 5 mmHg 2-24 hours after LTP

04: Tables IOP increase of > 5 mmHg 2-24 hours after LTP

04: Tables

05: Conclusions “Perioperative medications are superior to no medication or placebo to prevent intraocular pressure (IOP) spikes during the first two hours and up to 24 hours after laser trabeculoplasty (LTP).” “Future research on this topic could be with participants who have been using these antiglaucoma medications for daily treatment of glaucoma before having LTP to see whether there is a difference in their response to the medication given perioperatively.”

06: Acknowledgements Cochrane Eyes and Vision US Satellite, funded by the National Eye Institute, National Institutes of Health Cochrane Eyes and Vision Editorial Base, funded by the UK National Health Service Research and Development Programme Christopher J Brady, Andrea C Villanti, H Andrew Law, Ehsan Rahminy, Rahul Reddy, Pamela C Sieving, Sunir J Garg, Johnny Tang Review citation Brady CJ, Villanti AC, Law HA, Rahimy E, Reddy R, Sieving PC, Garg SJ, Tang J. Corticosteroid implants for chronic non-infectious uveitis. Cochrane Database of Systematic Reviews 2016, Issue 2. Art. No.: CD010469. DOI: 10.1002/14651858.CD010469.pub2.